// App-Quantinova.ai

9028 : Association of STK11/LKB1 mutations with primary resistance to PD-1/PD-L1 axis blockade in PD-L1 positive non-squamous NSCLC.

Researchers

Presenter

  • Ferdinandos Skoulidis

Principal Investigators

  • Brett W. Carter

  • Jianjun Zhang

  • Ignacio Ivan Wistuba

  • Vassiliki Papadimitrakopoulou

  • John Heymach

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Liver kinase B1

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Ticilimumab

  • Durvalumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved